Home » Public Policy » Policy Papers » E-Prescribing: Barriers and Opportunities
August 24, 2011
Electronic prescribing (also known as e-prescribing) is a system that enables providers in health care settings—e.g. doctors’ offices, hospitals, and long-term care facilities—to electronically write and store prescription information and send it directly to pharmacies.
There are two main types of e-prescribing systems:
Some e-prescribing systems also include advanced features that allow health care providers to access generic medication alternatives, drug formularies (insurance benefit information), and patients’ medication lists and histories (to check for drug allergies and interactions). These advanced features have the potential to enhance physicians’ decision-making capabilities and increase their use of e-prescribing.
Advocates of e-prescribing tout its potential for improving patient safety and lowering health care costs.1 Research indicates that e-prescribing is indeed a useful intervention for reducing the risk of medication errors and adverse drug events in hospital settings2 and increasing the selection of effective, less costly medications for hospitalized patients,3 but there is less evidence of its effectiveness in reducing medication errors in ambulatory settings.4
In the changing health information technology environment, various public-private collaboratives and state and federal initiatives are underway to encourage the adoption and use of e-prescribing among providers. In 2010, 25 percent of eligible prescriptions were sent electronically in the United States.5 Michigan ranks second in the U.S. for e-prescribing based on the following three factors in the e-prescribing process: 1) the percent of patient visits involving a prescription benefit request; 2) the percent of patient visits involving a medication history response; and 3) the percent of eligible prescriptions routed electronically. In Michigan, 20 percent of eligible prescriptions were ordered electronically in 2009, up from only 4 percent in 2007.6
Although the use of e-prescribing is increasing, providers continue to encounter significant barriers to the implementation and effective use of e-prescribing systems. It is important to understand these challenges in order to ensure the widespread adoption and effective use of e-prescribing.
In the last several years, e-prescribing has been the focus of both statewide legislation and regional public/private collaboratives. More recently, federal initiatives have been designed to incentivize providers to adopt e-prescribing systems. In 2008, Medicare began providing bonus payments to physicians who e-prescribed medications. Between 2008 and 2009, the electronic routing of prescriptions through Surescripts7 more than doubled nationally from 12.1 percent to 25 percent.8
Although e-prescribing is increasing in the United States, the vast majority of prescriptions are still not sent electronically. The use of e-prescribing among providers still lags behind policy goals, suggesting that policy and financial incentives alone are not enough to accelerate widespread adoption of e-prescribing.
A recent qualitative study by the Center for Studying Health System Change found that only 42 percent of physicians in office-based ambulatory settings had access to e-prescribing in 2008.9 Beyond lack of access to the technology, research shows that the lack of e-prescribing uptake in outpatient settings results from a number of key factors. Technological complexity, incomplete patient data, and physician attitudes toward e-prescribing all greatly affect the implementation and successful use of e-prescribing.
Many e-prescribing systems have advanced features that provide electronic access to important patient information, such as patient medication histories, formulary information, and generic alternatives. These features enhance the basic ability to write and store prescriptions electronically, but are not available in all e-prescribing systems. For example, in 2009 only 62 percent of the physicians who routed prescriptions electronically via Surescripts had access to medication histories, and just 60 percent had access to patient formularies. Even when physicians had access to these features, they did not always use them: 56 percent used the interface with patient medication histories most or all of the time and 34 percent used the interface with drug formularies most or all of the time.
E-prescribing system design varies by software vendor, and the technology is often complex and time consuming to use. Some systems display medication history prominently on the screen at the start of the prescribing session, and others require the prescriber to go through several steps to bring up that information. Not surprisingly, physicians are more likely to use the medication history feature in systems where it is readily available.
The same is true for formulary information, which allows the physician to view a list of medications covered by the patient’s health plan. Prescribers are much more likely to use e-prescribing systems to review a patient’s formulary details if the feature is automated and integrated into the workflow. Better systems let the prescriber know if an entered medication is on formulary, and if not, suggests alternative medications. More cumbersome systems do not offer these alternatives and require the prescriber to manually check each medication by trial and error.
The successful use of these features also depends on the availability and accuracy of patient information. Not all insurers share patient data with vendors for use in e-prescribing features, inhibiting consistent access for all patient medication histories and formularies. Physicians are much less likely to use these features if the data are not consistently available for all insured patients. And even when patient information is available, information can be out-of-date or incomplete. For example, medication history data is either entered manually by clinical staff10 or pulled from each participating health plans’ claims system reports. Medications which are paid for completely out-of-pocket are not included in the patient’s history, and in the era of retail pharmacies and four dollar generic drugs, incomplete medication histories are common.11
Another factor that can become a barrier to successful implementation and use of e-prescribing systems is provider expectations. For example, some physicians expect the technology to increase the speed of clinical care, and give up on using the system when they encounter difficulties and lack technical support.
Studies suggest that primary care physicians and practices that are more familiar with health information technology are more successful in fully implementing e-prescribing systems and managing expectations of the benefits. In fact, research also suggests ambulatory care practices that have successfully and fully implemented e-prescribing share common traits:
Like successful practices, those that have been unsuccessful in implementation share commonalities. In addition to a lack of familiarity with e-prescribing or other health information technology, these following contribute to their lack of e-prescribing use:
Other commonly identified barriers include increased costs, insufficient time for clinicians and staff to learn the new systems, and the additional effort needed to adapt office systems and manage technical difficulties. All of these factors would need to be addressed to realize the potential benefits of e-prescribing.
While many advocates of e-prescribing promote its use in improving health care safety, quality and efficiency, there are sizable gaps between the use of e-prescribing and policymakers’ vision for its widespread adoption. Governors, state agencies, and legislators have used various approaches to advance the adoption of e-prescribing by creating incentives, addressing policy barriers to implementation, and using regulatory authority to support e-prescribing goals. Given the relatively recent availability of federal funding established to encourage the use of e-prescribing, the number and diversity of these actions and initiatives continue to proliferate. (See Appendix for more information.) As states and the federal government work to advance e-prescribing use, it is important to understand what factors support or hinder its adoption and use among physicians.
Given the barriers to implementation and use, policymakers should consider multiple strategies to encourage widespread adoption. Beyond the financial support that many current e-prescribing initiatives provide, initiatives should address the availability of advanced features and patient data provided through these features, the complexity of the technology, and provider and staff understanding of implementation and use. Specifically, stakeholders and policymakers should consider the following in designing e-prescribing initiatives and incentives:
Michigan ranks second in the nation for e-prescribing. In 2009, 20 percent of eligible prescriptions were ordered electronically, up from only 4 percent in 2007.16 Two initiatives have played a key role in increasing the adoption of e-prescribing in Michigan:
Most recently, the Office of the National Coordinator for Health Information Technology awarded the Ann Arbor-based Altarum Institute over $19.6 million in 2010 to establish the Michigan Center for Effective IT Adoption (M-CEITA) as the state’s federally-designated regional extension center.18 M-CEITA is managed by Altarum and acts as Michigan’s resource for all issues related to health information technology (HIT) adoption and implementation. Beginning in 2015, the Patient Protection and Affordable Care Act of 2010 requires health care providers meet “meaningful use” standards to receive full Medicare and Medicaid reimbursement. M-CEITA will specifically help providers prepare to implement the meaningful use criteria for Electronic Health Records.19 As defined in the Health Information Technology for Economic and Clinical Health Act (HITECH) under the American Recovery and Reinvestment Act (ARRA), e-prescribing is a core objective of meaningful use and as such M-CEITA will continue to play a critical role in e-prescribing implementation.
E-prescribing is one of many strategies states have promoted in attempt to improve patient safety and quality of care while reducing health care costs. In addition to participating in statewide public/private collaboratives to influence e-prescribing, direct state influence typically falls under three categories: governor-initiated actions, implementation through Medicaid agencies, and enacted legislation.
Governors have played an important role in setting the stage for the adoption of e-prescribing in their respective states. Some governors have built support by establishing statewide initiatives charged with developing and/or implementing e-prescribing policy recommendations, launching communication campaigns to build awareness, and implementing regulatory changes, such as a requirement for e-prescribing adoption.
One of the best opportunities for states to have an impact on e-prescribing activities is by leveraging state-administered health care programs—mainly Medicaid. States are increasingly expanding Medicaid’s information technology systems to accommodate e-prescribing by linking the Medicaid Management Information Systems (MMIS) with e-prescribing networks.
New York:23 New York’s Medicaid program developed a program offering financial incentives to providers for e-prescribing with three goals: (1) reducing medication errors, (2) increasing patient safety, and (3) reducing costs. As of March 2010, the Medicaid program pays $0.80 to physicians and $0.20 to pharmacies for each electronically-prescribed medication for a Medicaid enrollee, and an additional incentive for refill prescriptions. Physicians are paid the incentive through quarterly bundled payments and the pharmacies receive payment when prescriptions are filled as an add-on in the dispensing fee. The program is strictly for incentive purposes and does not include any penalty for non-participating physicians or pharmacies. New York budgeted $119,504,000 for the program in FY2009-2010.
To establish this program, the Office of Health Insurance Programs (which administers New York’s Medicaid program) spent two years researching the potential impact of e-prescribing and working with various stakeholders to develop the program and gain legislative support. Stakeholders included representatives from Medicaid, the Office of Health Information Technology Transformation, and the State Pharmacy Board. The incentive program was developed based on the workgroup’s estimate that Medicaid would save $1.82 per each electronically-prescribed medication due to the decrease in medication errors and the cost of printing official New York paper prescriptions. The committee proposed that the cost savings be shared among Medicaid, the prescribing physician, and the pharmacy.24
All U.S. states have legislation that authorizes and permits e-prescribing as of August 2007. Similar to the executive orders issued by governors, some state legislatures have passed laws to specifically initiate or further encourage e-prescribing adoption and use.
In 2009, a bill was introduced requiring all pharmacies in the state to implement and use an e-prescribing system that is compatible with statewide interoperable electronic health records networks by January 1, 2012.
State actions and initiatives around e-prescribing are often inspired and/or supported by federal regulations, enacted legislation or available grant funding. The introduction of federal incentives in the last three years has sharpened the focus on e-prescribing nationwide, including the following actions:
1 Fischer MA, Solomon DH, Teich JM, and Avorn J. Conversation from intravenous to oral medications: assessment of a computerized intervention for hospitalized patients. Arch Intern Med 2006; 163:2585–2589.
2 Ammenwerth E, Schnell-Inderst P, Manchan C, and Siebert U. The Effect of Electronic Prescribing on Medication Errors and Adverse Drug Events: A Systematic Review. J Am Med Inform Assoc 2000; 15:585–600.
3 Fischer MA, Solomon DH, Teich JM, and Avorn J. Conversation from intravenous to oral medications: assessment of a computerized intervention for hospitalized patients. Arch Intern Med 2006; 163:2585–2589.
4 Friedman MA and Bell DS. E-Prescribing And The Medicare Modernization Act Of 2003. Health Affairs 2005; 24(5):1159-1169.
5 “The National Progress Report on E-Prescribing and Interoperable Healthcare,” Surescripts, 2010. Accessed from: http://www.surescripts.com/about-e-prescribing/progress-reports/national-progress-reports.aspx
6 “Michigan Progress Report on E-Prescribing,” Surescripts, 2010. Accessed from: http://www.surescripts.com/about-e-prescribing/progress-reports/state.aspx?state=mi
7 Surescripts operates the nation’s largest e-prescription network and works with health insurers and pharmacy benefit managers to provide physicians with access to external information like patient medication histories and formularies. Surescripts is the main intermediary e-prescribing system vendors use to provide physicians with access to these features.
8 Grossman, J, Boukus E, Cross D, and Cohen G. Even When Physicians Adopt E-Prescribing Use of Advanced Features Lags. Center for Studying Health System Change, Research Brief No. 20. May 2011.
9 Grossman, J, Boukus E, Cross D, and Cohen G. Even When Physicians Adopt E-Prescribing Use of Advanced Features Lags. Center for Studying Health System Change, Research Brief No. 20. May 2011.
10 Grossman J, Gerland A, Reed M, and Fahlman C. Physicians’ Experiences Using Commercial E-Prescribing Systems. Health Affairs 2007; 26(3):w393–w404.
11 Grossman, J, Boukus E, Cross D, and Cohen G. Even When Physicians Adopt E-Prescribing Use of Advanced Features Lags. Center for Studying Health System Change, Research Brief No. 20. May 2011.
12 Crosson J, Isaacson N, Lancaster D, et al. Variation in Electronic Prescribing Implementation Among Twelve Ambulatory Practices. J Gen Intern Med 2007; 23(4):364–371.
13 Fischer M, Vogeli C, Stedman M, et al. Uptake of Electronic Prescribing in Community-Based Practices. J Gen Intern Med 2007; 23(4):358–363.
14 Tamblyn R, Huang A, Kawasumi Y, Bartlett G, Grad R, Jacques A, et al. The development and evaluation of an integrated electronic prescribing and drug managed system for primary care. J Am Med Inform Assoc 2006; 13(2):148–159.
15 Grossman, J, Boukus E, Cross D, and Cohen G. Even When Physicians Adopt E-Prescribing Use of Advanced Features Lags. Center for Studying Health System Change, Research Brief No. 20. May 2011.
16 http://www.surescripts.com/about-e-prescribing/progress-reports/state.aspx?state=mi
17 “State of Michigan MiHIN Shared Services Strategic Plan,” DTMB, MDCH and Governor’s Office.
18 http://www.altarum.org/health-systems-research-news-releases/HHS-awards-Altarum-HIT-Grant
19 http://www.cms.gov/EHRIncentivePrograms/
20 NGA Center for Best Practices http://www.nga.org/cms/home/nga-center-for-best-practices/center-publications/page-health-publications/col2-content/main-content-list/accelerating-the-adoption-of-ele.html
21 “New Hampshire Progress Report on E-Prescribing,” SureScripts, 2010. Accessed from: http://www.surescripts.com/about-e-prescribing/progress-reports/state.aspx?state=nh
22 Agency for Health Care Administration, “Fourth Annual Florida 2010 Electronic Prescribing Report.” January 2011.
23 Agency for Healthcare Research and Quality, “Case Study – Developing an Electronic Prescribing Incentive Program: Lessons Learned From New York Medicaid.” July 2010. AHRQ Publication no. 10-0096-EF.
24 The Michigan Department of Community Health’s Fiscal Year 2010 Medicaid Strategic Plan for Electronic Prescribing includes evaluating the New York Medicaid e-prescribing incentives among its ongoing key activities for promoting e-prescribing adoption and use.
25 Agency for Health Care Administration, “Fourth Annual Florida 2010 Electronic Prescribing Report.” January 2011.
26 Minnesota Statutes, section 62J.497